Nathan Ng

Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV <i>EGFR</i> Variant–Positive Non–Small Cell Lung Cancer

Jiangdian Song, Lu Wang, Nathan Ng et al. · JAMA Network Open · 2020 · 64 citations · Full text

Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism

Mujib Ullah, Asma Akbar, Nathan Ng et al. · Oncotarget · 2019 · 61 citations · Full text

Association of Pediatric Acute-Onset Neuropsychiatric Syndrome With Microstructural Differences in Brain Regions Detected via Diffusion-Weighted Magnetic Resonance Imaging

Jimmy Zheng, Jennifer Frankovich, Emily McKenna et al. · JAMA Network Open · 2020 · 51 citations · Full text

A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study

Kexue Deng, Lu Wang, Yuchan Liu et al. · EClinicalMedicine · 2022 · 39 citations · Full text

Prognostic Evaluation, Oncology, Survival Benefit Prediction +11

Comparisons of dual isogenic human iPSC pairs identify functional alterations directly caused by an epilepsy associated SCN1A mutation

Yunyao Xie, Nathan Ng, Olga Safrina et al. · Neurobiology of Disease · 2019 · 36 citations · Full text

Scn1a Mutation, Functional Alterations, Genetics +17